🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🆕 Use of Sarilumab in Refractory PMR: SAPHYR Trial | Visual Abstract 🎨 🎲 Phase 3 RCT: Sarilumab vs Placebo 💉 Sarilumab: ⇡ sustained remission, ⇣ cumulative steroid 🥇 1st ever FDA approved medication for PMR #RheumTwitter #Rheumatology #PolymyalgiaRheumatica

Latest in Lupus Treatment at #ACR23 • Dr. Dall’Era & Dr. Furie • Approach to Lupus Nephritis 🫘 • Treating Non-Renal SLE / Skin #Lupus #RheumTwitter #Rheumatology

Approach to JOINT PAIN 🤚🏽 🔎 Qs to Differentiate Inflammatory vs Inflammatory ☀️ AM Stiffness? 🏃‍♀️ Better or Worse with Activity? ❓ Referrals: when to refer & to whom 🧪 When to Send “Autoimmune”/Rheum Labs and when *NOT* to send them #RheumTwitter #MedX #MedTwitter

🆕 Approach to Myositis (Inflammatory Myopathies) 🪄 💪🏽 Proximal Muscle Weakness 🖐️ Cutaneous (Gottron’s), Raynaud’s 🫁 Interstitial Lung Disease #RheumTwitter #MedTwitter #Myositis

🆕 #Vasculitis Demystified: An Approach to Systemic Vasculitides 🔥 • often characterized by SIZE of vessel • multi-system involvement: 🫁 Pulmonary 🫘 Renal 🤚🏽 Skin 👁️ Ocular #RheumTwitter #MedTwitter #MedX

🆕 Let’s Learn about Sarcoidosis! Created with @mwsharp5 ⭐️ Sarcoidosis = inflammatory condition characterized by NON-necrotizing granulomas • multi-system involvement 🫁🫀🧠👁️ • April is Sarcoidosis Awareness Month! #RheumTwitter #PulmTwitter #MedX

🆕 Visual Abstract with Healio Rheumatology 🟢 CD19 CAR-T Cell Therapy in Rheumatic Autoimmune Disease • Pts w/ SLE, IIM, SSc • CAR-T Cell therapy was safe/effective, all pts achieved disease remission 📖 by Muller et al, NEJM 🔗: tinyurl.com/CARTHealio #CARTCell #RheumTwitter

Review the latest on CD19 CAR T-Cell Therapy in Autoimmune Disease! #Lupus #Myositis #Scleroderma ⬇️ New Visual Abstract w/ Healio Rheumatology

🆕 Visual Abstract with Healio Rheumatology 🟢 Lymphadenopathy in #Rheum • Compare LAD in SLE, RA, SjD, sarcoid, IgG4-RD • Identify red flags for malignancy • Recognize features of Castleman's 📖 by Stefano Rodolfi Puja Mehta 🧩 🌻 David Fajgenbaum, MD et al 🔗: bit.ly/3WJj0GJ

🦋 New Visual Abstract with Healio Rheumatology 🟢 • Environmental factors that may contribute to #lupus are poorly understood • This study showed ⬆️ Ultraprocessed Food (UPF) Intake is associated with ⬆️ risk of developing SLE 📖 by Rossato et al 🔗: bit.ly/3MqroEU

🆕 Visual Abstract with Healio Rheumatology 🟢 Are herbal supplements safe in autoimmune disease? Recent Study shows herbal supplement use can be associated with exacerbation /⬆️ in Dermatomyositis and Cutaneous Lupus flares🌱 📖 by Faden et al Werth Lab 🔗: tinyurl.com/herbalDM

🆕 Infographic on Systemic Lupus Erythematosus! • Recognize signs/symptoms of #lupus and when SLE should be on your DDx • Learn what labs to send if you suspect SLE: And don’t forget to ☑️ UA/UPC ratio! 🫘 #RheumTwitter #MedX #MedTwitter #NephTwitter #Rheumatology

🔶Clinical Year in Review #ACR24 🔶 Talk By Michael Pillinger • Review some of the most impactful studies in Rheumatology from the past year! #RheumTwitter #Rheumatology

🆕 #ACR24 | Updated Guidelines for Lupus Nephritis Treatment & Management 🫘 Highlights 🔶 • Critical role of renal biopsy • Differences for treatment by LN Class • Adjunctive Rx w/ HCQ & RAASi • GC pulse ⇢ *moderate/low* dose PDN #Lupus #NephTwitter #RheumTwitter

🆕 #Obinutuzumab (Obi) in Lupus Nephritis: the REGENCY Trial Phase 3 RCT: Obi vs PBO 🫘 Pts w/ SLE nephritis Class III/IV ± 5 🎲 Randomized 1:1 to OBI v PBO (+MMF/steroids) 📊 Obi: ⇡rate of renal response #LupusNephritis #RheumTwitter #NephTwitter #Lupus

💫 Check out the new #RheumMadness x @ RheumOnePagers Bracket Infographic 🏀📟 📚 Read the most innovative #rheum articles (last 2 yrs) 🎧 Check out the Rheum Madness Podcasts 🗳️ Submit your Brackets before April 1, 2025 Collaboration with Rheum Madness Team x @DavidLeverenz

🆕 PJP Prophylaxis in #Rheumatology 🫁 Created with / Review by Cassandra Calabrese 🔹Discuss risk factors for PJP infection 🔹Risk Stratify: CD4 count <200 or ALC <500 = ⇡Risk 🔹Review Treatment options and when to stop PPx? #RheumX #RheumTwitter #PulmTwitter #PJP

1/10 We are proud to share a review of the CNS manifestations of SLE by Rheum OnePagers and @Neudrawlogy! Here you will learn: The neuropsychiatric manifestations of SLE Pathophysiology Labs & imaging data analysis How to treat it A 🧵! (For educational purposes only)

🆕 Check out our new tweetorial with Neudrawlogy on an approach to CNS Lupus / Lupus Cerebritis! 🧠

🆕 2024 ACR Guidelines for Screening, Treatment and Management of #Lupus Nephritis🦋 • Just Released: May 7, 2025 🔥 🔸New Recommendations for Triple Therapy for Class III/IV + V 🔸Reduced ⇣ Dose of PO Steroids after IV Pulse! #LupusNephritis #RheumX #RheumTwitter #SLE